Hitto Kaufmann
Chief Tech/Sci/R&D Officer presso PIERIS PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Hitto Kaufmann is currently holding four jobs.
He is the Vice Chairman at European Society For Animal Cell Technology, Co-Managing Director at Pieris Pharmaceuticals GmbH, Chief Scientific Officer at Hansa Biopharma AB, and Chief Scientific Officer & Senior Vice President at Pieris Pharmaceuticals, Inc. Dr. Kaufmann has previously worked as Global Head-Strategy & Operations at Sanofi and Vice President-Process Science at Boehringer Ingelheim Corp.
He has a graduate degree from The Scripps Research Institute, a doctorate degree from Swiss Federal Institute of Technology, and a graduate degree from Technische Universität Braunschweig.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 24/02/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Hitto Kaufmann
| Società | Posizione | Inizio |
|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/08/2019 |
| HANSA BIOPHARMA AB | Chief Tech/Sci/R&D Officer | 01/12/2023 |
| European Society For Animal Cell Technology | Director/Board Member | - |
Pieris Pharmaceuticals GmbH
 Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Part of Pieris Pharmaceuticals, Inc., Pieris Pharmaceuticals GmbH operates as a German biotechnology company. The private company is based in Hallbergmoos, Germany. The CEOs of the company are Hitto Kaufmann, Stephen S. Yoder. | Chief Executive Officer | - |
Precedenti posizioni note di Hitto Kaufmann
| Società | Posizione | Fine |
|---|---|---|
| SANOFI | Chief Operating Officer | 02/01/2019 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Formazione di Hitto Kaufmann
| The Scripps Research Institute | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
| Technische Universität Braunschweig | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SANOFI | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Part of Pieris Pharmaceuticals, Inc., Pieris Pharmaceuticals GmbH operates as a German biotechnology company. The private company is based in Hallbergmoos, Germany. The CEOs of the company are Hitto Kaufmann, Stephen S. Yoder. | Health Technology |
| European Society For Animal Cell Technology |
- Borsa valori
- Insiders
- Hitto Kaufmann
